- BioPharm International
BioPharm International is the independent source for technical solutions and business insight for biopharmaceutical research, development, and manufacturing
- BioPharm International May 2025
BioPharm International is the independent source for technical solutions and business insight for biopharmaceutical research, development, and manufacturing
- BioPharm International, March 2025
BioPharm International is the independent source for technical solutions and business insight for biopharmaceutical research, development, and manufacturing
- BioPharm International, JanuaryFebruary 2025
BioPharm International is the independent source for technical solutions and business insight for biopharmaceutical research, development, and manufacturing
- All News | Biopharma News - BioPharm International
BioPharm International® spoke with Jason Bock, founder and CEO of CTMC, to find out about the newest cancer treatments, specifically developments in tumor-infiltrating lymphocytes Regeneron Receives Positive Opinion from EMA for Relapsed and Refractory Multiple Myeloma
- About BioPharm International
BioPharm International integrates the science and business of biopharmaceuticals, covering all aspects of biopharmaceutical research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging, as well as business strategies and regulatory issues
- All News - BioPharm International
BioPharm International is the independent source for technical solutions and business insight for biopharmaceutical research, development, and manufacturing
- AAPS National Biotechnology Conference 2025: High-Concentration Biologics
BioPharm International ® spoke with Xin about these challenges associated with the formulation of high-concentration biologics ahead of his presentation at the AAPS National Biotechnology Conference, which is being held May 4–7, 2025 in Boston Xin’s presentation, “Accelerating High Concentration Formulation Development with Big Data
|